secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001193125-23-250341
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Grégory Behar resigns from Seres Therapeutics board effective Oct 2, 2023
--------------------------------------------------------------------------------

- Grégory Behar resigned from the board effective October 2, 2023.
- Resignation follows his departure from Nestlé Health Science.
- No replacement or additional board changes were announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312523250341/0001193125-23-250341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312523250341/d547449d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-250341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer